Cefprozil NDC 0093-1077

NDC codes

FDA NDC Directory

Product NDC (as listed)0093-1077Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00093-1077Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0093-1077-01	00093107701	100 TABLET, FILM COATED in 1 BOTTLE (0093-1077-01)Marketed from Dec 23, 2005

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Cefprozil
Generic name (nonproprietary): cefprozil
Active ingredients: Cefprozil — 250 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Teva Pharmaceuticals USA, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 065208
Marketing start: Dec 23, 2005
Listing expires: Dec 31, 2026
Identifiers: Product ID 0093-1077_c226712f-00c2-407f-8b40-5ed1be54dfb8SPL ID c226712f-00c2-407f-8b40-5ed1be54dfb8SPL set ID 3391de8b-7bc9-4624-a5c4-836135b39d99RxCUI 197452, 197453UNII 4W0459ZA4V

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400093107701 followed by a unit qualifier and the quantity

Package 00093-1077-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 31, 2018.

Indications (excerpt from the label)

INDICATIONS AND USAGE Cefprozil tablets are indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions listed below: UPPER RESPIRATORY TRACT Pharyngitis/tonsillitis caused by Streptococcus pyogenes . NOTE: The usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever, is penicillin given by the intramuscular route. Cefprozil is generally effective in the eradication of Streptococcus pyogenes from the nasopharynx; however, substantial data establishing the efficacy of cefprozil in the subsequent prevention of rheumatic fever are no…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 065208

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 065208
Product	Strength	Form · route	Labeler	Product NDC
Cefprozil	Cefprozil 500 mg/1	Tablet, Film coatedOral	Teva Pharmaceuticals USA, Inc.	0093-1078